Menu
GeneBe

TFPI

tissue factor pathway inhibitor

Basic information

Region (hg38): 2:187464229-187565760

Previous symbols: [ "LACI" ]

Links

ENSG00000003436NCBI:7035OMIM:152310HGNC:11760Uniprot:P10646AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TFPI gene.

  • Inborn genetic diseases (4 variants)
  • not provided (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFPI gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
4
clinvar
1
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 4 0 2

Variants in TFPI

This is a list of pathogenic ClinVar variants found in the TFPI region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-187466990-T-G not specified Uncertain significance (Feb 27, 2023)2489839
2-187466997-C-G not specified Uncertain significance (May 31, 2022)2386004
2-187467037-T-C not specified Uncertain significance (Oct 25, 2023)3176556
2-187467833-C-T not specified Uncertain significance (Sep 26, 2023)3176555
2-187467845-A-G not specified Uncertain significance (Dec 26, 2023)3176554
2-187467924-C-T not specified Uncertain significance (Feb 23, 2023)2471857
2-187484116-A-G Benign (Mar 05, 2018)786733
2-187484906-G-T Benign (Jun 06, 2018)775182
2-187496871-A-G Benign (Aug 06, 2018)791880
2-187497060-A-G not specified Uncertain significance (Sep 01, 2021)2247864

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TFPIprotein_codingprotein_codingENST00000233156 7101531
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2480.751125502071255090.0000279
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.311131590.7090.000007982021
Missense in Polyphen2756.20.48043741
Synonymous0.5934853.50.8970.00000265523
Loss of Function2.81416.20.2479.92e-7187

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004630.0000462
European (Non-Finnish)0.00004840.0000440
Middle Eastern0.000.00
South Asian0.00004350.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.;
Pathway
Complement and coagulation cascades - Homo sapiens (human);Integrated Breast Cancer Pathway;Dengue-2 Interactions with Complement and Coagulation Cascades;Complement and Coagulation Cascades;Extrinsic Pathway of Fibrin Clot Formation;Hemostasis;Formation of Fibrin Clot (Clotting Cascade);Syndecan-4-mediated signaling events;extrinsic prothrombin activation pathway (Consensus)

Recessive Scores

pRec
0.321

Intolerance Scores

loftool
0.754
rvis_EVS
0.33
rvis_percentile_EVS
73.27

Haploinsufficiency Scores

pHI
0.308
hipred
N
hipred_score
0.292
ghis
0.446

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.930

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tfpi
Phenotype
skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Gene ontology

Biological process
blood coagulation;blood coagulation, extrinsic pathway;negative regulation of endopeptidase activity;negative regulation of blood coagulation;response to estradiol;cellular response to lipopolysaccharide;cellular response to interleukin-1;cellular response to steroid hormone stimulus
Cellular component
extracellular region;extracellular space;endoplasmic reticulum;plasma membrane;caveola;cell surface;organelle membrane;anchored component of membrane
Molecular function
endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity